As of 4:02pm ET
| +0.17 / +2.08%|
The 1 analysts offering 12-month price forecasts for Medgenics Inc have a median target of 11.50, with a high estimate of 11.50 and a low estimate of 11.50. The median estimate represents a +37.72% increase from the last price of 8.35.
The current consensus among 1 polled investment analysts is to Buy stock in Medgenics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.